Atlas Trials

A Clinical Study Evaluating the Safety and Efficacy of Local Injection of ACT#001 Chimeric Antigen Receptor T Cells in the Treatment of Castration-Resistant Prostate Cancer

Clinical trial NCT07240857 · ENROLLING_BY_INVITATION

Trial details

NCT number
NCT07240857
Sponsor
Zhejiang University
Status
ENROLLING_BY_INVITATION
Phase
Early Phase 1
Study type
INTERVENTIONAL
Castration-Resistant Prostate Cancer (CRPC)
Start date
2026-04-12
Primary completion
2026-10-31
Enrollment
18

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.